Pharmacopsychiatry 2001; 34(2): 73-79
DOI: 10.1055/s-2001-15181
Original Paper
© Georg Thieme Verlag Stuttgart · New York

Effects of Risperidone on Event-related Potentials in Schizophrenic Patients

A. Iwanami1 Y. Okajima2 H. Isono2 J. Shinoda2 K. Kasai1 A. Hata1 M. Fukuda3 K. Nakagome2 K. Kamijima2
  • 1 Department of Neuropsychiatry, Faculty of Medicine, University of Tokyo
  • 2 Department of Psychiatry, Showa University School of Medicine
  • 3 Department of Neuropsychiatry, Faculty of Medicine, Gunma University
Further Information

Publication History

Publication Date:
31 December 2001 (online)

In order to examine the effects of risperidone on cognitive impairment in schizophrenia, event-related potentials (ERPs) were recorded before and after switching from conventional neuroleptics to risperidone in schizophrenic patients. ERPs were recorded during two auditory discrimination tasks (an oddball task and a distraction task) in 10 medicated schizophrenic patients during conventional neuroleptic and risperidone treatments. The amplitudes and latencies of N 100 and P 300 component were measured in ERPs for target stimuli in the oddball task and in ERPs for target and novel stimuli in the distraction task. Although N 100 amplitude and latency and P 300 amplitude did not change significantly after switching the drug compared to that during conventional neuroleptic treatment, P 300 latency for target stimuli shortened significantly during risperidone treatment in both tasks, accompanied by the shortening of the reaction time in the distraction task. The P 300 latency change did not correlate with the change of the severity of psychopathology. These findings suggest that risperidone may speed the information processing in schizophrenic patients, contributing to the improvement of cognitive functions.

References

  • 1 Bellack A S, Gold J M, Buchanan R W. Cognitive rehabilitation for schizophrenia: Problems, prospects, and strategies.  Schizophr Bull. 1999;  25 257-274
  • 2 Meltzer H Y, McGurk S R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.  Schizophr Bull. 1999;  25 233-255
  • 3 Lindstrom E, von Knorring L. Changes in single symptoms and separate factors of the schizophrenic syndrome after treatment with risperidone or haloperidol.  Pharmacopsychiatry. 1994;  27 108-113
  • 4 Maurer K, Dierks T, Laux G, Rupprecht R, Ihl R. Topographic mapping of EEG and auditory evoked P 300 in neuropsychopharmacology.  Pharmacopsychiatry. 1988;  21 338-342
  • 5 Donchin E, Coles M GH. Is the P 300 component a manifestation of context updating?.  Behav Brain Sci. 1988;  11 357-374
  • 6 Pritchard W S. Cognitive event-related potentials in schizophrenics.  Psychological Bulletin. 1986;  100 43-66
  • 7 Iwanami A, Okajima Y, Kuwakado D, Isono H, Kasai K, Hata A. et al . Event-related potentials and thought disorder in schizophrenia.  Schizophr. Res. 2000;  42 189-191
  • 8 Egan M F, Duncan C C, Suddath R L, Kirch D G, Mirsky A F, Wyatt R J. Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia.  Schizophr Res. 1994;  11 259-271
  • 9 Hegerl U, Juckel G, Muller-Schubert A, Pietzcker A, Gaebel W. Schizophrenics with small P 300: a subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia?.  Acta Psychiatr Scand. 1995;  91 120-125
  • 10 Iwanami A, Yamashina M, Kazamatsuri H, Kamijima K. P 300 and disability of daily life in schizophrenia.  Prog Neuropsychopharmacol Biol Psychiatry. 1999;  23 423-430
  • 11 Kasai K, Okazawa K, Nakagome K, Hiramatsu K, Hata A. et al . Mismatch negativity and N 2b attenuation as an indicator for dysfunction of the preattentive and controlled processing for deviance detection in schizophrenia: a topographic event-related potential study.  Schizophr Res. 1999;  35 141-156
  • 12 Iwanami A, Isono H, Okajima Y, Noda Y, Kamijima K. Event-related potentials during a selective attention task with short interstimulus intervals in patients with schizophrenia.  J Psychiatry Neurosci. 1998;  23 45-50
  • 13 American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington D. C American Psychiatric Association 1994
  • 14 Spitzer R L, Endicott J. Schedule for affective disorders and schizophrenia. Lifetime version. New York, NY; Biometric Research, New York State Psychiatric Association 1978
  • 15 Grillon C, Courchesne E, Ameli R, Geyer M A, Braff D L. Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence.  Arch Gen Psychiatry. 1990;  47 171-179
  • 16 Overall J E, Gorham D R. The brief psychiatric rating scale.  Psychol Rep. 1962;  10 799-812
  • 17 Blackwood D H, Whalley L J, Christie J E, Blackburn I M, St. Clair D M, McInnes A. Changes in auditory P 3 event-related potential in schizophrenia and depression.  Br J Psychiatry. 1987;  150 154-160
  • 18 Faux S F, McCarley R W, Nestor P G, Shenton M E, Pollak S D, Penhune V. et al . P 300 topographic asymmetries are present in non-medicated schizophrenics.  Electroencephalogr Clin Neurophysiol. 1993;  88 32-41
  • 19 Roxborough H, Muir W J, Blackwood D H, Walker M T, Blackburn I M. Neuropsychological and P 300 abnormalities in schizophrenics and their relatives.  Psychol Med. 1993;  23 305-314
  • 20 Shajahan P M, O’Carroll R E, Glabus M F, Ebmeier K P, Blackwood D H. Correlation of auditory „oddball” P 300 with verbal memory deficits in schizophrenia.  Psychol Med. 1997;  27 579-586
  • 21 O’Donnell B F, Faux S F, McCarley R W, Kimble M O, Salisbury D F, Nestor P G, et a l. et al . Increased rate of P 300 latency prolongation with age in schizophrenia. Electrophysiological evidence for a neurodegenerative process.  Arch Gen Psychiatry. 1995;  52 544-549
  • 22 Salisbury D F, Shenton M E, Sherwood A R, Fischer I A, Yurgelun-Todd D A, Tohen M. et al . First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P 300 amplitude over left temporal lobe.  Arch Gen Psychiatry. 1998;  55 173-180
  • 23 Pfefferbaum A, Ford J M, White P M, Roth W T. P 3 in schizophrenia is affected by stimulus modality, response requirements, medication status, and negative symptoms.  Arch Gen Psychiatry. 1989;  46 1035-1044
  • 24 Coburn K L, Shillcutt S D, Tucker K A, Estes K M, Brin F B, Merai P. et al . P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication.  Biol Psychiatry. 1998;  44 466-474
  • 25 Duncan C C. Event-related brain potentials: a window on information processing in schizophrenia.  Schizophr Bull. 1988;  14 199-203
  • 26 Kutas M, McCarthy G, Donchin E. Augmenting mental chronometry: the P 300 as a measure of stimulus evaluation time.  Science. 1977;  197 792-795
  • 27 McCarthy G, Donchin E. A metric for thought: a comparison of P300 latency and reaction time.  Science. 1981;  211 77-80
  • 28 Duncan-Johnson C C, Donchin E. The P 300 component of the event-related brain potential as an index of information processing.  Biol Psychology. 1982;  14 1-52
  • 29 Umbricht D, Javitt D, Novak G, Bates J, Pollack S, Lieberman J. et al . Effects of clozapine on auditory event-related potentials in schizophrenia.  Biol Psychiatry. 1998;  44 716-725
  • 30 Kern R S, Green M F, Marshall J r. BD, Wirshing WC, Wirshing D, McGurk S, et al. Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients.  Biol Psychiatry. 1998;  44 726-732
  • 31 Rossi A, Mancini F, Stratta P, Mattei P, Gismondi R, Pozzi F. et al . Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.  Acta Psychiatr Scand. 1997;  95 40-43
  • 32 Green M F, Marshall Jr B D, Wirshing W C, Ames D, Marder S R, McGurk S. et al . Does risperidone improve verbal working memory in treatment-resistant schizophrenia?.  Am J Psychiatry. 1997;  154 799-804
  • 33 Kern R S, Green M F, Marshall Jr B D, Wirshing W C, Wirshing D, McGurk S. et al . Risperidone versus haloperidol on secondary memory: can newer medications aid learning?.  Schizophr Bull. 1999;  25 223-232
  • 34 Honey G D, Bullmore E T, Soni W, Varatheesan M, Williams S CR, Sharma T. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.  Proc Natl Acad Sci U.S.A.. 1999;  96 13 432-13 437
  • 35 Hansen J C, Hillyard S A. Endogenous brain potentials associated with selective auditory attention.  Electroencephalogr Clin Neurophysiol. 1980;  49 277-290
  • 36 Squires N K, Squires K C, Hillyard S A. Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man.  Electroencephalogr Clin Neurophysiol. 1975;  38 387-401
  • 37 Knight R T. Decreased response to novel stimuli after prefrontal lesions in man.  Electroencephalogr Clin Neurophysiol. 1984;  59 9-20

Dr. Akira Iwanami

Department of Neuropsychiatry
Faculty of Medicine, University of Tokyo

7-3-1 Hongo

Bunkyoku, Tokyo 113-8655

Japan

Phone: +81-3-3815-5411

Fax: +81-3-5800-6894

Email: iwanami-tky@umin.ac.jp)